IRIS

PANE, FABRIZIO

PANE, FABRIZIO  

DIPARTIMENTO DI MEDICINA CLINICA E CHIRURGIA  

Mostra records
Risultati 1 - 20 di 407 (tempo di esecuzione: 0.055 secondi).
Titolo Tipologia Data di pubblicazione Autore(i) File
DIRECT-DETECTION OF PROVIRAL GAG SEGMENT OF HUMAN-IMMUNODEFICIENCY-VIRUS IN PERIPHERAL-BLOOD LYMPHOCYTES BY COLORIMETRIC PCR ASSAY AS A CLINICAL LABORATORY TOOL APPLIED TO DIFFERENT AT-RISK POPULATIONS 1.1 Articolo in rivista 1995 Pane, Fabrizio; Butto, S.; Gobbo, M. L.; Franco, M.; Butteroni, C.; Pastore, Lucio; Maiorano, G.; Foggia, M.; Cataldo, P. T.; Guarino, A.; Tamburrini, E.; Solinas, S.; Piazza, M.; Vecchio, Giancarlo; Verani, P.; Salvatore, Francesco
XM02 PLUS CHEMOTHERAPY IS SAFE AND EFFECTIVE IN STEM CELL MOBILIZATION FOR PATIENTS CANDIDATED TO AUTOLOGOUS STEM CELL TRANSPLANTATION 4.2 Abstract in Atti di convegno 2013 Grimaldi, Francesco; Madonna, Emanuela; Avilia, Simona; Ricci, P.; Andretta, Claudia; Pane, Fabrizio; Risitano, ANTONIO MARIA; DE ROSA, Gennaro
In vitro acquired cellular senescence and aging specific phenotype can be distinguished on the basis of specific mRNA expression. 1.1 Articolo in rivista 2002 Faraonio, Raffaella; Pane, Fabrizio; Intrieri, M.; Russo, Tommaso; Cimino, F.
In vitro acquired cellular senescence and aging-specific phenotype can be distinguished on the basis of specific mRNA expression 1.1 Articolo in rivista 2002 Faraonio, Raffaella; Pane, Fabrizio; Intrieri, M; Russo, T; AND CIMINO, F.
Late relapse of acute promyelocytic leukemia treated with all- trans retinoic acid and chemotherapy: report of two cases. 1.1 Articolo in rivista 2004 F., Ferrara; Selleri, Carmine; G., Mele; Serio, Bianca; S., Palmieri; B., Pocali; Pane, Fabrizio; Rotoli, Bruno
JURL-MK1 (c-kit(high)/CD30-/CD40-) and JURL-MK2 (c-kit(low)/CD30+/CD40+) cell lines: 'two-sided' model for investigating leukemic megakaryocytopoiesis. 1.1 Articolo in rivista 1997 DI NOTO, Rosa; Luciano, Luigia; Lo Pardo, C.; Ferrara, F.; Frigeri, F.; Mercuro, O.; Lombardi, M. L.; Pane, Fabrizio; Vacca, C.; Manzo, C.; Salvatore, Francesco; Rotoli, Bruno; DEL VECCHIO, Luigi
Trisomy 13 in a case of myelofibrosis with myeloid metaplasia with early blastic transformation. 1.1 Articolo in rivista 1995 Ferrara, F.; Vicari, L.; Festa, B.; DI NOTO, Rosa; Pane, Fabrizio; Sebastio, L.; Cimino, R.
Specific messanger RNA as indicators of neoplasia. 4.1 Articoli in Atti di convegno 2000 Salvatore, F.; Sacchetti, L.; Castaldo, Giuseppe; Pane, Fabrizio
ALEMTUZUMAB FOR APLASTIC ANEMIA AND RELATED IMMUNE-MEDIATED BONE MARROW FAILURES: LONG-TERM FOLLOW UP OF A PILOT STUDY 1.5 Abstract in rivista 2011 Risitano, ANTONIO MARIA; Selleri, Carmine; Serio, Bianca; Marando, L.; Marotta, Serena; Raia, M.; De Palma, R.; DEL VECCHIO, Luigi; DE ROSA, Gennaro; Pane, Fabrizio
Selective strong synergism of Ruxolitinib and second generation tyrosine kinase inhibitors to overcome bone marrow stroma related drug resistance in chronic myelogenous leukemia. 1.1 Articolo in rivista 2013 Quintarelli, Concetta; DE ANGELIS, Biagio; Errichiello, S; Caruso, S; Esposito, N; Colavita, I; Raia, M; Pagliuca, S; Pugliese, N; Risitano, ANTONIO MARIA; Picardi, Marco; Luciano, L; Saglio, G; Martinelli, G; Pane, Fabrizio
Cytological and histological detection of amyloid deposits in bone marrow of patients affected by multiple myeloma. 1.1 Articolo in rivista 2011 Petruzziello, F; Zeppa, P; Ciancia, G; Cozzolino, I; Fernandez, Ls; Cervasio, M; Musto, P; D'Auria, F; Vita, G; Morabito, F; Piro, E; Ponti, Mr; Pettinato, G; Ciancia, R; Pane, Fabrizio; Catalano, Lucio
Phase III, randomized, open-label study of daily imatinib mesylate 400 mg versus 800 mg in patients with newly diagnosed, previously untreated chronic myeloid leukemia in chronic phase using molecular end points: tyrosine kinase inhibitor optimization and selectivity study. 1.1 Articolo in rivista 2010 Cortes, Je; Baccarani, M; Guilhot, F; Druker, Bj; Branford, S; Kim, Dw; Pane, Fabrizio; Pasquini, R; Goldberg, Sl; Kalaycio, M; Moiraghi, B; Rowe, Jm; Tothova, E; De Souza, C; Rudoltz, M; Yu, R; Krahnke, T; Kantarjian, Hm; Radich, Jp; Hughes, Tp
Fused FDG-PET/contrast-enhanced CT detects occult subdiaphragmatic involvement of Hodgkin's lymphoma thereby identifying patients requiring six cycles of anthracycline-containing chemotherapy and consolidation radiation of spleen. 1.1 Articolo in rivista 2011 Picardi, Marco; Soricelli, A; Grimaldi, F; Nicolai, E; Gallamini, A; Pane, Fabrizio
Variant Philadelphia translocations: molecular-cytogenetic characterization and prognostic influence on frontline imatinib therapy, a GIMEMA Working Party on CML analysis. 1.1 Articolo in rivista 2011 Marzocchi, G; Castagnetti, F; Luatti, S; Baldazzi, C; Stacchini, M; Gugliotta, G; Amabile, M; Specchia, G; Sessarego, M; Giussani, U; Valori, L; Discepoli, G; Montaldi, A; Santoro, A; Bonaldi, L; Giudici, G; Cianciulli, Am; Giacobbi, F; Palandri, F; Pane, Fabrizio; Saglio, G; Martinelli, G; Baccarani, M; Rosti, G; Testoni, N; Gruppo Italiano Malattie EMatologiche dell'Adulto Working Party on Chronic Myeloid, Leukemia
Comparison between patients with Philadelphia-positive chronic phase chronic myeloid leukemia who obtained a complete cytogenetic response within 1 year of imatinib therapy and those who achieved such a response after 12 months of treatment 1.1 Articolo in rivista 2006 Iacobucci, I; Rosti, G; Amabile, M; Poerio, A; Soverini, S; Cilloni, D; Testoni, N; Abruzzese, E; Montefusco, E; Ottaviani, E; Iuliano, F; Russo, D; Gobbi, M; Alimena, G; Martino, B; Terragna, C; Pane, Fabrizio; Saglio, G; Baccarani, M; Martinelli, G.
Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia. 1.1 Articolo in rivista 2010 Saglio, G; Kim, Dw; Issaragrisil, S; le Coutre, P; Etienne, G; Lobo, C; Pasquini, R; Clark, Re; Hochhaus, A; Hughes, Tp; Gallagher, N; Hoenekopp, A; Dong, M; Haque, A; Larson, Ra; Kantarjian, Hm; Moiraghi, B; Perez, M; Greil, R; Valent, P; Bosly, A; Martiat, P; Noens, L; André, M; Verhoef, G; Conchon, M; Souza, C; Nonino, A; Hungria, V; Zanichelli, Ma; Colturato, V; Forrest, D; Lipton, Jh; Savoie, Ml; Delage, R; Lalancette, M; Quintero, G; Gomez, M; Klamova, H; Faber, E; Bjerrum, Ow; Fredriksen, H; Vestergaard, H; Marcher, C; Kamel, H; Elzawam, H; Porkka, K; Remes, K; Reiffers, J; Guilhot, F; Facon, T; Tulliez, M; Guerci Bresler, Ap; Nicolini, Fe; Charbonnier, A; Rea, D; Johnson Ansah, A; Legros, L; Harousseau, Jl; Rigal Huguet, F; Escoffre, M; Gardembas, M; Guyotat, D; Cahn, Jy; Gattermann, N; Ottmann, O; Niederwieser, D; Stegelmann, F; Schafhausen, P; Brümmendorf, T; Duyster, J; Blumenstengel, K; Scheid, C; Kneba, M; Kwong, Yl; Masszi, T; Petrini, M; Alimena, G; Di Raimondo, F; Rosti, G; Rotoli, B; Pane, Fabrizio; Pungolino, E; Amadori, S; Abruzzese, E; Fioritoni, G; Lauria, F; Bosi, A; Martelli, M; Rambaldi, A; Ferrara, F; Nobile, F; Gobbi, M; Carella, Am; Orlandi, Em; Leoni, P; Tiribelli, M; Levis, A; Imamura, M; Takahashi, N; Tsukamoto, N; Chiba, S; Nagai, T; Okamoto, S; Miura, O; Kurokawa, M; Ohnishi, K; Toba, K; Nakao, S; Tomita, A; Miyamura, K; Hino, M; Maeda, Y; Kimura, A; Kawaguchi, T; Miyazaki, Y; Nakaseko, C; Jinnai, I; Matsuda, A; Matsumura, I; Ishikawa, J; Ohyashiki, K; Okada, M; Usuki, K; Kobayashi, Y; Ohishi, K; Imai, K; Miyawaki, S; Kanda, Y; Park, Sy; Kim, Hj; Sohn, Sk; Lee, Kh; Jung, Cw; Ong, Tc; Gómez Almaguer, D; Kassack, J; Ossenkoppele, Gj; Gedde Dahl, T; Hjorth Hansen, H; Jedrzejczak, W; Dmoszynska, A; Starzak Dwozdz, J; Holowiecki, J; Kyrcz Krzemieñ, S; Kuliczkowski, K; Zaritsky, A; Turkina, A; Pospelova, T; Goh, Yt; Koh, Lp; Demitrovicova, L; Mistrik, M; Ruff, P; Louw, V; Dreosti, Lm; Novitzky, N; Cohen, G; Cervantes, F; Cañizo, C; de Paz, R; del Castillo, S; Perez Encinas, M; Sanz Alonso, M; Marin, F; Pérez López, R; Hernandez Boluda, J; Echeveste Gutierrez, Ma; Odriozola, J; Herrera, P; Steegman, Jl; Conde, E; Lopez, P; Giraldo, P; Boque, C; Heredia, B; Font, Aj; Rodriguez, Rf; Rodriguez, Mj; Batlle, J; Stenke, L; Lehmann, S; Wadenvik, H; Simonsson, B; Markevärn, B; Själander, A; Richter, J; Bjoreman, M; Eriksson, Km; Chalandon, Y; Shih, Ly; Yao, M; Wang, Mc; Jootar, S; Bunworasate, U; Ulkü, B; Haznedar, R; Undar, B; Sahin, B; Marin, D; Smith, G; Byrne, J; Holyoake, T; Kalaycio, M; Akard, L; Heaney, M; Al Janadi, A; Goldberg, S; Powell, B; Harker, Wg; Shea, T; Gingrich, R; Glass, J; Paquette, R; Siegrist, C; Woodson, M; Fehrenbacher, L; Koh, H; Flinn, I; Arrowsmith, E; Ervin, T; Guerra, M; Wallach, H; Berry, W; Burke, J; Edenfield, W; Guzley, G; Davis, J; Richards, D; Schlossman, D; Kolibaba, K; Alemany, C; Savin, M; Robbins, G; Lopez, J; Goldman, Jm; Camm, J; Schiffer, Ca; Sargent, D. J.
Serum pseudouridine in the diagnosis of acute leukaemias and as a novel prognostic indicator in acute lymphoblastic leukaemia 1.1 Articolo in rivista 1993 Pane, Fabrizio; Savoia, Marcella; Fortunato, G.; Camera, A.; Rotoli, B.; Salvatore, F.; Sacchetti, L.
Discontinuation of imatinib therapy after achievement of complete molecular response in a Ph(+) CML patient treated while in long lasting complete cytogenetic remission (CCR) induced by interferon 1.1 Articolo in rivista 2006 Breccia, M; Diverio, D; Pane, Fabrizio; Nanni, M; Russo, E; Biondo, F; Frustaci, A; Gentilini, F; Alimena, G.
Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet 1.1 Articolo in rivista 2009 Baccarani, M; Cortes, J; Pane, Fabrizio; Niederwieser, D; Saglio, G; Apperley, J; Cervantes, F; Deininger, M; Gratwohl, A; Guilhot, F; Hochhaus, A; Horowitz, M; Hughes, T; Kantarjian, H; Larson, R; Radich, J; Simonsson, B; Silver, Rt; Goldman, J; Hehlmann, R; European, L. e. u. k. e. m. i. a. N. e. t.
WT1 transcript amount discriminates secondary or reactive eosinophilia from idiopathic hypereosinophilic syndrome or chronic eosinophilic leukemia 1.1 Articolo in rivista 2007 Cilloni, D; Messa, F; Martinelli, G; Gottardi, E; Arruga, F; Defilippi, I; Carturan, S; Messa, E; Fava, M; Giugliano, E; Rosso, V; Catalano, R; Merante, S; Nicoli, P; Rondoni, M; Ottaviani, E; Soverini, S; Tiribelli, M; Pane, Fabrizio; Baccarani, M; Saglio, G.